MarketInOut Stock Screener Log In | Sign Up

Island Pharmaceuticals Ltd

Healthcare • Biotechnology • Quote as of 10/29/2026 16:10
Island Pharmaceuticals Ltd stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
Market Capitalization96.17 mln
Float149 mln
Earnings Date03/03/2027

Piotroski F-Score

4 / 9
Borderline

Relative Strength

28 / 100
Underperforming

ROE

-106
Deeply negative

ROA

-100
Deeply negative

Business Description

Island Pharmaceuticals is an Australian biotech company working to give existing medicines new purpose by developing treatments for viral diseases. Founded in 2017 and operating across Australia and the United States, the company is focused on fighting mosquito-borne illnesses such as dengue fever. Its primary drug candidate, ISLA-101, is being developed to both prevent and treat these infections.

Key Fundamentals

EPS-0.04
ROE-106
RPS0.00
ROIC-1,733
ROA-100
EBITDA, mln-10.02
EV / EBITDA-7.88
EV / EBIT-7.79
Revenue, mln0.28
EV / Revenue279

Quote Details

Last 0.325
Change 0 (0%)
Open 0.33
Volume 64,707
Turnover 21,030
Average Volume 207,930

Financial Ratios

Leverage Ratio1.04
Current Ratio24.62
Price / Book7.22
Price / Tangible Book8.13

Financial Strength

Piotroski F-Score 4 / 9

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.56% 73 / 100   
1 Month -10.96% 32 / 100   
2 Months -19.75% 22 / 100   
6 Months -12.16% 40 / 100   
1 Year -17.72% 39 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog